Humoral immune response after primary rubella virus infection and after vaccination. 2007

C Vauloup-Fellous, and L Grangeot-Keros
Service de Microbiologie-Immunologie Biologique, Hôpital Antoine Béclère, and Faculté de Médecine, Université Paris-Sud, Clamart Cedex, France. christelle.vauloup@abc.aphp.fr

We measured rubella virus immunoglobulin G (IgG) and IgM levels, as well as IgG avidity indexes, in serum samples taken before or after 6 months either after infection or after vaccination. The results obtained indicate that humoral immune responses are different after primary infection and after vaccination. This may have important consequences on the serological diagnosis of rubella virus infection.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D012409 Rubella An acute infectious disease caused by the RUBELLA VIRUS. The virus enters the respiratory tract via airborne droplet and spreads to the LYMPHATIC SYSTEM. Measles, German,Three Day Measles,German Measles,Measle, Three Day,Measles, Three Day,Rubellas,Three Day Measle
D012411 Rubella Vaccine A live attenuated virus vaccine of duck embryo or human diploid cell tissue culture origin, used for routine immunization of children and for immunization of nonpregnant adolescent and adult females of childbearing age who are unimmunized and do not have serum antibodies to rubella. Children are usually immunized with measles-mumps-rubella combination vaccine. (Dorland, 28th ed) Vaccine, Rubella
D012412 Rubella virus The type (and only) species of RUBIVIRUS causing acute infection in humans, primarily children and young adults. Humans are the only natural host. A live, attenuated vaccine is available for prophylaxis. Measles Virus, German,German Measles Virus

Related Publications

C Vauloup-Fellous, and L Grangeot-Keros
March 2006, Clinical and vaccine immunology : CVI,
C Vauloup-Fellous, and L Grangeot-Keros
November 1985, British medical journal (Clinical research ed.),
C Vauloup-Fellous, and L Grangeot-Keros
October 1973, Clinical and experimental immunology,
C Vauloup-Fellous, and L Grangeot-Keros
June 1993, The Journal of infectious diseases,
C Vauloup-Fellous, and L Grangeot-Keros
May 1982, Infection and immunity,
C Vauloup-Fellous, and L Grangeot-Keros
June 1995, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
C Vauloup-Fellous, and L Grangeot-Keros
June 2005, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi,
C Vauloup-Fellous, and L Grangeot-Keros
August 1974, Clinical and experimental immunology,
C Vauloup-Fellous, and L Grangeot-Keros
January 1988, Quaderni Sclavo di diagnostica clinica e di laboratorio,
Copied contents to your clipboard!